Wilsen Craig B, Patel Maitraya K, Douek Michael L, Masamed Rinat, Dittmar Kristin M, Lu David S K, Raman Steven S
UCLA Department of Radiological Sciences, University of California Los Angeles, David Geffen School of Medicine, 757 Westwood Plaza, Los Angeles, CA, 90095, USA.
Beverly Hills Cancer Center, Beverly Hills, CA, USA.
Abdom Radiol (NY). 2023 Apr;48(4):1438-1453. doi: 10.1007/s00261-023-03804-5.
Since FDA approval for contrast-enhanced ultrasound (CEUS), clinical applications have increased to include diagnostic imaging of hepatic, renal, and other abdominal lesions. The modality has also demonstrated utility in certain image-guided procedures. Intravascular ultrasound contrast agents use microbubbles to improve visibility of solid tumors. Lesions not well seen on grayscale or Doppler ultrasound may become amenable to CEUS-guided biopsy or ablation.
This pictorial essay provides eleven examples to illustrate the current use of CEUS in a variety of abdominal image-guided procedures. Hepatic, renal, peritoneal, and soft tissue cases are presented.
CEUS can improve visualization and targeting in abdominal image-guided procedures, without nephrotoxicity or radiation exposure.
自美国食品药品监督管理局（FDA）批准超声造影（CEUS）以来，其临床应用不断增加，已涵盖肝脏、肾脏及其他腹部病变的诊断成像。该技术在某些图像引导操作中也显示出实用性。血管内超声造影剂利用微泡来提高实体瘤的可视性。在灰阶或多普勒超声上显示不佳的病变可能适合进行CEUS引导下的活检或消融。
本文通过11个实例阐述了CEUS目前在各种腹部图像引导操作中的应用。展示了肝脏、肾脏、腹膜及软组织病例。
CEUS可改善腹部图像引导操作中的可视化及靶向性，且无肾毒性或辐射暴露风险。
